Theralase Technologies (TSE:TLT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Theralase Technologies, a company focusing on innovative cancer treatments, reported a decrease in revenues and a net loss for the nine-month period ending September 30, 2024. Despite a significant international sales increase, overall revenue dropped by 12%, while operating expenses were reduced by 7%.
For further insights into TSE:TLT stock, check out TipRanks’ Stock Analysis page.
